Találati lista | Tudóstér

001-es BibID:	BIBFORM057538
035-os BibID:	(scopus)84910122146 (wos)000345023400059
Első szerző:	Govers, Coen
Cím:	TCRs genetically linked to CD28 and CD3[epszilon] do not mispair with endogenous TCR chains and mediate enhanced t cell persistence and anti-melanoma activity / Coen Govers, Zsolt Sebestyén, János Roszik, Mandy van Brakel, Cor Berrevoets, Árpád Szöőr, Konstantina Panoutsopoulou, Marieke Broertjes, Tan Van, György Vereb, János Szöllősi, Reno Debets
Dátum:	2014
ISSN:	0022-1767 1550-6606
Megjegyzések:	Adoptive transfer of T cells that are gene engineered to express a defined TCR represents a feasible and promising therapy for patients with tumors. However, TCR gene therapy is hindered by the transient presence and effectiveness of transferred T cells, which are anticipated to be improved by adequate T cell costimulation. In this article, we report the identification and characterization of a novel two-chain TCR linked to CD28 and CD3[epszilon] (i.e., TCR:28[epszilon]). This modified TCR demonstrates enhanced binding of peptide-MHC and mediates enhanced T cell function following stimulation with peptide compared with wild-type TCR. Surface expression of TCR:28[epszilon] depends on the transmembrane domain of CD28, whereas T cell functions depend on the intracellular domains of both CD28 and CD3[epszilon], with IL-2 production showing dependency on CD28:LCK binding. TCR:28[epszilon], but not wild-type TCR, induces detectable immune synapses in primary human T cells, and such immune synapses show significantly enhanced accumulation of TCR transgenes and markers of early TCR signaling, such as phosphorylated LCK and ERK. Importantly, TCR:28[epszilon] does not show signs of off-target recognition, as evidenced by lack of TCR mispairing, as well as preserved specificity. Notably, when testing TCR:28[epszilon] in immune-competent mice, we observed a drastic increase in T cell survival, which was accompanied by regression of large melanomas with limited recurrence. Our data argue that TCR transgenes that contain CD28, and, thereby, may provide T cell costimulation in an immune-suppressive environment, represent candidate receptors to treat patients with tumors.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk TCR T Cell
Megjelenés:	Journal Of Immunology. - 193 : 10 (2014), p. 5315-5326. -
További szerzők:	Sebestyén Zsolt Roszik János (1979-) (biofizikus) van Brakel, Mandy Berrevoets, Cor Szöőr Árpád (1984-) (orvos) Panoutsopoulou, Konstantina Broertjes, Marieke Van, Tan Vereb György (1965-) (biofizikus, orvos) Szöllősi János (1953-) (biofizikus) Debets, Reno
Pályázati támogatás:	TÁMOP-4.2.1/B-09/1/KONV-2010-0007 TÁMOP TÁMOP-4.2.2/B-10/1/2010-0024 TÁMOP TÁMOP-4.2.2/A-11/1/KONV-20120025 TÁMOP OTKA-NK101337 OTKA
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM020768
Első szerző:	Roszik János (biofizikus)
Cím:	T-cell synapse formation depends on antigen recognition but not CD3 interaction : studies with TCR : zeta, a candidate transgene for TCR gene therapy / Roszik J., Sebestyén Z., Govers C., Guri Y., Szöor A., Pályi-Krekk Z., Vereb G., Nagy P., Szöllosi J., Debets R.
Dátum:	2011
Megjegyzések:	T-cell receptors (TCRs) can be genetically modified to improve gene-engineered T-cell responses, a strategy considered critical for the success of clinical TCR gene therapy to treat cancers. TCR:zeta, which is a heterodimer of TCRalpha and beta chains each coupled to complete human CD3zeta, overcomes issues of mis-pairing with endogenous TCR chains, shows high surface expression and mediates antigen-specific T-cell functions in vitro. In the current study, we further characterized TCR:zeta in gene-engineered T cells and assessed whether this receptor is able to interact with surface molecules and drive correct synapse formation in Jurkat T cells. The results showed that TCR:zeta mediates the formation of synaptic areas with antigen-positive target cells, interacts closely with CD8alpha and MHC class I (MHCI), and co-localizes with CD28, CD45 and lipid rafts, similar to WT TCR. TCR:zeta did not closely associate with endogenous CD3epsilon, despite its co-presence in immune synapses, and TCR:zeta showed enhanced synaptic accumulation in T cells negative for surface-expressed TCR molecules. Notably, synaptic TCR:zeta demonstrated lowered densities when compared with TCR in dual TCR T cells, a phenomenon that was related to both extracellular and intracellular CD3zeta domains present in the TCR:zeta molecule and responsible for enlarged synapse areas
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban Adoptive Transfer Antigens Antigens,CD28 Antigens,CD3 Antigens,CD45 Antigens,CD8 article Biophysics Cells Flow Cytometry Gene Therapy genetics Histocompatibility Antigens Histocompatibility Antigens Class I Human Humans Hungary Immunity,Cellular Immunological Synapses immunology In Vitro Jurkat Cells lipid raft LIPID RAFTS Membrane Microdomains metabolism physiology Receptor-CD3 Complex,Antigen,T-Cell Receptors,Antigen,T-Cell,alpha-beta Research Research Support Support Synapses T-Lymphocytes therapy Transgenes
Megjelenés:	European Journal of Immunology. - 41 : 5 (2011), p. 1288-1297. -
További szerzők:	Sebestyén Zsolt Govers, Coen Guri, Yakir Szöőr Árpád (1984-) (orvos) Pályiné Krekk Zsuzsanna (1974-) (molekuláris biológus) Vereb György (1965-) (biofizikus, orvos) Nagy Péter (1971-) (biofizikus) Szöllősi János (1953-) (biofizikus) Debets, Reno
Internet cím:	DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM039658
035-os BibID:	(scopus)0036628631 (wos)000176656500002
Első szerző:	Sebestyén Zsolt
Cím:	Long wavelength fluorophores and cell-by-cell correction for autofluorescence significantly improves the accuracy of flow cytometric energy transfer measurements on a dual-laser benchtop flow cytometer / Zsolt Sebestyén, Péter Nagy, Gábor Horváth, György Vámosi, Reno Debets, Jan W. Gratama, Denis R. Alexander, János Szöllősi
Dátum:	2002
ISSN:	0196-4763
Megjegyzések:	Flow cytometric fluorescence resonance energy transfer (FCET) is an efficient method to map associations between biomolecules because of its high sensitivity to changes in molecular distances in the range of 1-10 nm. However, the requirement for a dual-laser instrument and the need for a relatively high signal-to-noise system (i.e., high expression level of the molecules) pose limitations to a wide application of the method.METHODS:Antibodies conjugated to cyanines 3 and 5 (Cy3 and Cy5) were used to label membrane proteins on the cell surface. FCET measurements were made on a widely used benchtop dual-laser flow cytometer, the FACSCalibur, by using cell-by-cell analysis of energy transfer efficiency.ResultsTo increase the accuracy of FCET measurements, we applied a long wavelength donor-acceptor pair, Cy3 and Cy5, which beneficially affected the signal-to-noise ratio in comparison with the classic pair of fluorescein and rhodamine. A new algorithm for cell-by-cell correction of autofluorescence further improved the sensitivity of the technique; cell subpopulations with only slightly different FCET efficiencies could be identified. The new FCET technique was tested on various direct and indirect immunofluorescent labeling strategies. The highest FCET values could be measured when applying direct labeling on both (donor and acceptor) sides. Upon increasing the complexity of the labeling scheme by introducing secondary antibodies, we detected a decrease in the energy transfer efficiency.CONCLUSIONS:We developed a new FCET protocol by applying long wavelength excitation and detection of fluorescence and by refining autofluorescence correction. The increased accuracy of the new method makes cells with low receptor expression amenable to FCET investigation, and the new approach can be implemented easily on a commercially available dual-laser flow cytometer, such as a FACSCalibur.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk Algorithms analysis Antibodies Biophysics Calibration Cell Line, Transformed Cells Comparative Study Dyes Energy Transfer Flow Cytometry Fluorescein Fluorescence Fluorescence Resonance Energy Transfer Fluorescent Dyes Humans Hungary instrumentation Lasers Membrane Proteins methods Proteins Reproducibility of Results Research Spectrometry, Fluorescence Subtraction Technique Support Tumor Cells, Cultured egyetemen (Magyarországon) készült közlemény
Megjelenés:	Cytometry. - 48 : 3 (2002), p. 124-135. -
További szerzők:	Nagy Péter (1971-) (biofizikus) Horváth Gábor (1974-) (biofizikus) Vámosi György (1967-) (biofizikus) Debets, Reno Gratama, Jan Willem Alexander, Denis R. Szöllősi János (1953-) (biofizikus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM005192
035-os BibID:	(WOS)000257507300075
Első szerző:	Sebestyén Zsolt
Cím:	Human TCR that incorporate CD3 zeta induce highly preferred pairing between TCR alpha and beta chains following gene transfer / Zsolt Sebestyén, Erik Schooten, Tamara Sals, Irene Zaldivar, Esther San José, Balbino Alarcón, Sara Bobisse, Antonio Rosato, János Szöllősi, Jan Willem Gratama, Ralph A. Willemsen, Reno Debets
Dátum:	2008
ISSN:	0022-1767
Megjegyzések:	TCR gene therapy is adversely affected by newly formed TCR alpha beta heterodimers comprising exogenous and endogenous TCR chains that dilute expression of transgenic TCR alpha beta dimers and are potentially self-reactive. We have addressed TCR mispairing by using a modified two-chain TCR that encompasses total human CD3 with specificities for three different Ags. Transfer of either TCR alpha:CD3 zeta or beta:CD3 zeta genes alone does not result in surface expression, whereas transfer of both modified TCR chains results in high surface expression, binding of peptide-MHC complexes and Ag-specific T cell functions. Genetic introduction of TCR alpha beta:CD3 zeta does not compromise surface expression and functions of an endogenous TCR alpha beta. Flow cytometry fluorescence resonance energy transfer and biochemical analyses demonstrate that TCR alpha beta:CD3 zeta is the first strategy that results in highly preferred pairing between CD3 zeta-modified TCR alpha and beta chains as well as absence of TCR mispairing between TCR:CD3 zeta and nonmodified TCR chains. Intracellular assembly and surface expression of TCR:CD3 zeta chains is independent of endogenous CD3 gamma, 8 delta, and epsilon. Taken together, our data support the use of TCR alpha beta:CD3 zeta to prevent TCR mispairing, which may provide an adequate strategy to enhance efficacy and safety of TCR gene transfer.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk Energy Transfer Flow Cytometry Fluorescence Fluorescence Resonance Energy Transfer Gene Therapy Human Support therapy
Megjelenés:	Journal of Immunology. - 180 : 11 (2008), p. 7736-7746. -
További szerzők:	Schooten, Erik Sals, Tamara Zaldivar, Irene San José, Esther Alarcón, Balbino Bobisse, Sara Rosato, Antonio Szöllősi János (1953-) (biofizikus) Gratama, Jan Willem Willemsen, Ralph A. Debets, Reno
Internet cím:	DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: